1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase inhibitors
US-2024343711-A1 · Oct 17, 2024 · US
This page is not indexed by search engines while we improve data quality.
Copmans Alex patents
Copmans Alex is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Copmans Alex |
| Total patents | 8 |
| First publication | Aug 18, 2015 |
| Latest publication | Oct 17, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitors
US-10738032-B2 · Aug 11, 2020 · US
1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase inhibitors
US-2019185458-A1 · Jun 20, 2019 · US
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
US-10266519-B2 · Apr 23, 2019 · US
1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase inhibitors
US-2018134687-A1 · May 17, 2018 · US
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
US-9850231-B2 · Dec 26, 2017 · US
1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase inhibitors
US-2016009695-A1 · Jan 14, 2016 · US
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors
US-9108950-B2 · Aug 18, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Respivert Ltd | 10 |
Top CPC classifications
Most common classification codes across this inventor's patents.